CoMentis comentis.com


Public lists: Pharma Startups (4733)

CoMentis is focused on developing drugs to treat various central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company covers the research and development spectrum from initial drug design through manufacturing and clinical trials.

CoMentis is focused on developing drugs to treat various central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company covers the research and development spectrum from initial drug design through manufacturing and...Show all

Company (Alive / Active)

Phone: 650-869-7600

Fax:

400 Oyster Point Blvd.
Suite 226
South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CoMentis $82.2M Mar 18, 2016
CGI Pharmaceuticals $56.9M Jun 25, 2010
Hyperion Therapeutics $206.6M Mar 30, 2015
See all 27 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CoMentis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors
See all 27 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Quinuclidines for modulating alpha 7 activity Jul 08, 2015 Sep 06, 2016 Patent
Chromane compounds Jan 22, 2015 Jan 26, 2016 Patent
Chromane compounds Feb 27, 2014 Mar 10, 2015 Patent
4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof Sep 30, 2008 Feb 14, 2012 Patent
Hydroxyethylene-based β-secretase inhibitors and use thereof Sep 19, 2005 Feb 09, 2010 Patent
See all 6 patents